Robert Boorstein, MD, PhD
Bellevue Hospital Center
Robert Boorstein, MD, PhD, is the Director of Pathology at Bellevue Hospital and an Associate Professor in the Department of Pathology at New York University School of Medicine. He is also the Medical Director for Pathology and Laboratory Medicine of the South Manhattan Healthcare Network and Northern Manhattan and Generations plus Health Network of the New York Center Health and Hospitals Corporation. Dr. Boorstein has experience in providing laboratory services with interest in molecular diagnostics and other emerging technologies. His basic science interests have focused on mechanisms of DNA damage and repair, and targets of anti-neoplastic therapy. (This is me - Update Profile)
| 1996 - present | Director of Pathology Bellevue Hospital Center |
|---|---|
| 1983 - present | Associate Professor of Pathology New York University School of Medicine/ Medical Center |
GLG Study Groups with Robert Boorstein, MD, PhD(?)
| Study Group Name | Members |
|---|---|
| Pathologists (US) | 810 |
| Galileo Users | 13 |
| Users of Provue system for blood screening | 13 |
| Digene-HPV DNA Panel Users: Pathologists (US) | 22 |
GLG NewsSM
Analyses by Robert Boorstein, MD, PhD(?)
Pharmaceutical companies spend over $10,000 per physician on direct gifts and similar activities. These activities are designed to influence prescribing patterns, and most certainly do. Monitoring sales of drug classes as drugs come off patent, as in anti allergy medications, drugs for acid...
The last several years as seen the growth of financial incentives to stimulate improvements in patient safety and patient outcomes. Clearly society has an interest in improving patient safety, and aligning providers and payers financially is a laudable goal. The use of denied payments raises the...
How much will Abbott contribute to bottom line of GE.What is future of Abbott.
Approval of the Mammaprint is a significant advance clinically, as it is the first FDA approved gene expression test for breast cancer. If it is widely accepted, it would represent one of the highest value cancer diagnostic products. The technology would presumably be extended to other common...
GLG InstituteSM Seminars with Robert Boorstein, MD, PhD(?)
View all GLG InstituteSM Seminars in Healthcare
Request a project with Robert Boorstein, MD, PhD
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms